Business
Bionano Announces Leadership Transition
SAN DIEGO, May 06, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Al Luderer, Ph.D., chairman of Bionano’s Board of Directors, has been appointed interim president and chief executive officer, effective May 5, 2026. Dr. Luderer will continue to serve as chairman, and director Chris Twomey will serve as Lead Independent Director. He succeeds Erik Holmlin, PhD, who is staying on as an advisor. The company anticipates a seamless transition without business disru
About this update from Bionano Genomics, Inc.
[{"type":"image","alt":"Bionano Genomics","displaySize":"","headline":null,"caption":"Bionano Genomics","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":61,"url":"https://media.zenfs.com/en/globenewswire.com/b39fec01655bcf34db9e215be03042b1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/BL0NoL0PFOcUTHrfwl5LaQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTg1/https://media.zenfs.com/en/globenewswire.com/b39fec01655bcf34db9e215be03042b1","width":300,"height":61}},"lazy":false},{"type":"text","content":"SAN DIEGO, May 06, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Al Luderer, Ph.D., chairman of Bionano’s Board of Directors, has been appointed interim president and chief executive officer, effective May 5, 2026. Dr. Luderer will continue to serve as chairman, and director Chris Twomey will serve as Lead Independent Director. He succeeds Erik Holmlin, PhD, who is staying on as an advisor. The company anticipates a seamless transition without business disruption.","length":506,"tagName":"p"},{"type":"text","content":"Dr. Luderer brings both deep industry experience and knowledge of Bionano having served on its Board of Directors since November 2011 and served as Chairman of its Board of Directors since June 2024. Dr. Luderer has three decades of experience in biotechnology, with special focuses on technology, business development and commercialization. Dr. Luderer previously served as CEO of Indi Molecular, president and CEO of BioTrove, CEO of Light Sciences and president and COO of bioMérieux, Inc.","length":492,"tagName":"p"},{"type":"text","content":""I am honored to step into this role and deeply committed to Bionano's mission and the long-term opportunity we are pursuing,” said Dr. Luderer, interim president and chief executive officer of Bionano. “Having worked closely with this team as Chairman, I have a clear view of both the strengths of this organization and the work ahead. I look forward to working alongside our talented employees, partners, and shareholders to maintain momentum and position Bionano well for its next chapter of growth, and look forward to working with the Board on identifying our next CEO. I also want to thank Erik for his contributions and dedication to Bionano.”","length":659,"tagName":"p"},{"type":"text","content":""Al brings an extraordinary co...